Global On-body Injectors Market Growth 2025-2031

Publication ID:

LPI04253460

Publication Date:

April 22, 2025

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global On-body Injectors market size is predicted to grow from US$ 195 million in 2025 to US$ 465 million in 2031; it is expected to grow at a CAGR of 15.6% from 2025 to 2031.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
The 鈥淥n-body Injectors Industry Forecast鈥� looks at past sales and reviews total world On-body Injectors sales in 2024, providing a comprehensive analysis by region and market sector of projected On-body Injectors sales for 2025 through 2031. With On-body Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world On-body Injectors industry.
This Insight Report provides a comprehensive analysis of the global On-body Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on On-body Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global On-body Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for On-body Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global On-body Injectors.
This report presents a comprehensive overview, market shares, and growth opportunities of On-body Injectors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Electronic Injectors
Mechanical Injectors
Segmentation by Application:
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Key Questions Addressed in this Report
What is the 10-year outlook for the global On-body Injectors market?
What factors are driving On-body Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do On-body Injectors market opportunities vary by end market size?
How does On-body Injectors break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global On-body Injectors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for On-body Injectors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for On-body Injectors by Country/Region, 2020, 2024 & 2031
2.2 On-body Injectors Segment by Type
2.2.1 Electronic Injectors
2.2.2 Mechanical Injectors
2.3 On-body Injectors Sales by Type
2.3.1 Global On-body Injectors Sales Market Share by Type (2020-2025)
2.3.2 Global On-body Injectors Revenue and Market Share by Type (2020-2025)
2.3.3 Global On-body Injectors Sale Price by Type (2020-2025)
2.4 On-body Injectors Segment by Application
2.4.1 Immuno-oncology
2.4.2 Cardiovascular Diseases
2.4.3 Neurological Diseases
2.4.4 Others
2.5 On-body Injectors Sales by Application
2.5.1 Global On-body Injectors Sale Market Share by Application (2020-2025)
2.5.2 Global On-body Injectors Revenue and Market Share by Application (2020-2025)
2.5.3 Global On-body Injectors Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global On-body Injectors Breakdown Data by Company
3.1.1 Global On-body Injectors Annual Sales by Company (2020-2025)
3.1.2 Global On-body Injectors Sales Market Share by Company (2020-2025)
3.2 Global On-body Injectors Annual Revenue by Company (2020-2025)
3.2.1 Global On-body Injectors Revenue by Company (2020-2025)
3.2.2 Global On-body Injectors Revenue Market Share by Company (2020-2025)
3.3 Global On-body Injectors Sale Price by Company
3.4 Key Manufacturers On-body Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers On-body Injectors Product Location Distribution
3.4.2 Players On-body Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for On-body Injectors by Geographic Region
4.1 World Historic On-body Injectors Market Size by Geographic Region (2020-2025)
4.1.1 Global On-body Injectors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global On-body Injectors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic On-body Injectors Market Size by Country/Region (2020-2025)
4.2.1 Global On-body Injectors Annual Sales by Country/Region (2020-2025)
4.2.2 Global On-body Injectors Annual Revenue by Country/Region (2020-2025)
4.3 Americas On-body Injectors Sales Growth
4.4 APAC On-body Injectors Sales Growth
4.5 Europe On-body Injectors Sales Growth
4.6 Middle East & Africa On-body Injectors Sales Growth
5 Americas
5.1 Americas On-body Injectors Sales by Country
5.1.1 Americas On-body Injectors Sales by Country (2020-2025)
5.1.2 Americas On-body Injectors Revenue by Country (2020-2025)
5.2 Americas On-body Injectors Sales by Type (2020-2025)
5.3 Americas On-body Injectors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC On-body Injectors Sales by Region
6.1.1 APAC On-body Injectors Sales by Region (2020-2025)
6.1.2 APAC On-body Injectors Revenue by Region (2020-2025)
6.2 APAC On-body Injectors Sales by Type (2020-2025)
6.3 APAC On-body Injectors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe On-body Injectors by Country
7.1.1 Europe On-body Injectors Sales by Country (2020-2025)
7.1.2 Europe On-body Injectors Revenue by Country (2020-2025)
7.2 Europe On-body Injectors Sales by Type (2020-2025)
7.3 Europe On-body Injectors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa On-body Injectors by Country
8.1.1 Middle East & Africa On-body Injectors Sales by Country (2020-2025)
8.1.2 Middle East & Africa On-body Injectors Revenue by Country (2020-2025)
8.2 Middle East & Africa On-body Injectors Sales by Type (2020-2025)
8.3 Middle East & Africa On-body Injectors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of On-body Injectors
10.3 Manufacturing Process Analysis of On-body Injectors
10.4 Industry Chain Structure of On-body Injectors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 On-body Injectors Distributors
11.3 On-body Injectors Customer
12 World Forecast Review for On-body Injectors by Geographic Region
12.1 Global On-body Injectors Market Size Forecast by Region
12.1.1 Global On-body Injectors Forecast by Region (2026-2031)
12.1.2 Global On-body Injectors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global On-body Injectors Forecast by Type (2026-2031)
12.7 Global On-body Injectors Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
13.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Insulet
13.2.1 Insulet Company Information
13.2.2 Insulet On-body Injectors Product Portfolios and Specifications
13.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Insulet Main Business Overview
13.2.5 Insulet Latest Developments
13.3 Gerresheimer
13.3.1 Gerresheimer Company Information
13.3.2 Gerresheimer On-body Injectors Product Portfolios and Specifications
13.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Gerresheimer Main Business Overview
13.3.5 Gerresheimer Latest Developments
13.4 United Therapeutics
13.4.1 United Therapeutics Company Information
13.4.2 United Therapeutics On-body Injectors Product Portfolios and Specifications
13.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 United Therapeutics Main Business Overview
13.4.5 United Therapeutics Latest Developments
13.5 CC Bio
13.5.1 CC Bio Company Information
13.5.2 CC Bio On-body Injectors Product Portfolios and Specifications
13.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CC Bio Main Business Overview
13.5.5 CC Bio Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD On-body Injectors Product Portfolios and Specifications
13.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed On-body Injectors Product Portfolios and Specifications
13.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 Enable Injections
13.8.1 Enable Injections Company Information
13.8.2 Enable Injections On-body Injectors Product Portfolios and Specifications
13.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Enable Injections Main Business Overview
13.8.5 Enable Injections Latest Developments
13.9 Nemera
13.9.1 Nemera Company Information
13.9.2 Nemera On-body Injectors Product Portfolios and Specifications
13.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nemera Main Business Overview
13.9.5 Nemera Latest Developments
13.10 Stevanato Group
13.10.1 Stevanato Group Company Information
13.10.2 Stevanato Group On-body Injectors Product Portfolios and Specifications
13.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Stevanato Group Main Business Overview
13.10.5 Stevanato Group Latest Developments
13.11 Sonceboz
13.11.1 Sonceboz Company Information
13.11.2 Sonceboz On-body Injectors Product Portfolios and Specifications
13.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sonceboz Main Business Overview
13.11.5 Sonceboz Latest Developments
13.12 Lohmann Therapie-Systeme
13.12.1 Lohmann Therapie-Systeme Company Information
13.12.2 Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
13.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lohmann Therapie-Systeme Main Business Overview
13.12.5 Lohmann Therapie-Systeme Latest Developments
13.13 Elcam Drug Delivery Devices (E3D)
13.13.1 Elcam Drug Delivery Devices (E3D) Company Information
13.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
13.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Elcam Drug Delivery Devices (E3D) Main Business Overview
13.13.5 Elcam Drug Delivery Devices (E3D) Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂